There is a gap in American healthcare.
We are closing it.
Practitioners spend nearly half their working day on administration — not medicine. Phones ring unanswered. Voicemails pile up. Patients give up. Not because they don’t need care. Because the system makes it too hard to be seen.
What can be prevented is not prevented. Not because the doctor lacks the skill — but because the patient could not get on the schedule.
IB365 answers every call. Schedules every patient. Gives practitioners back the time to practice medicine — and patients the access they deserve.
Medicine is being buried under paperwork.
- 23 min/hrspent on admin tasks — not patient care
- $14,000average cost to replace one medical assistant
- 47%of practices say MA roles are hardest to fill
- 27–35%of after-hours calls go unanswered
Sources: MGMA, BLS, Tebra Practice Survey 2025
- 82%of patients give a practice 1–2 chances before switching
- 63%switch providers due to poor communication
- 15%average patient portal adoption — industry standard
- 78%of preventable hospitalizations tied to missed follow-up
Sources: Tebra Patient Experience Report, JABFM, Artera, AMA
One platform. Every interaction covered.
IB365 replaces 4–6 separate systems with a single AI-native front office. Voice. Portal. CRM. Fully integrated. Already in production.
Aveena — Voice AI
Answers every call, 24/7. Schedules appointments, handles FAQs, transfers complex cases. English and Spanish. Never a voicemail.
MyCare — Patient Portal
Passwordless patient access. Appointment history, messaging, lab results, scheduling. 80% adoption at Advanced Psychiatry vs 15% industry average.
Practice CRM
Complete patient and lead management. Communication history, follow-ups, staff workflows, and reporting — all in one place.
In production. Not a pitch.
Advanced Psychiatry — one practice, in production. This is the current weekly volume. Not a projection. Not a pilot. Live.
Data from Advanced Psychiatry, Las Vegas, NV — IB365 production deployment. Current weekly volume. No projections.
Participate in every patient IB365 serves.
As IB365 grows its practice base, you earn a monthly return tied directly to the number of tenants on the platform. Accessible. Transparent. Growing.
$60,000 already committed by early believers. Two agreements signed. $100,000 available on a first-come basis — minimum $5,000.
How it works
You invest
Choose an amount from $5,000 to the $160,000 remaining. Simple revenue sharing agreement.
Tenants generate MRR
Each healthcare practice pays $799/month. Your return is proportional to your investment.
You receive monthly distributions
For every $1,000 invested, you receive $1/month per active tenant on the platform.
Projected monthly returns by investment
Returns grow as IB365 adds tenants. At 100 practices, a $20,000 investment is fully returned within 10 months. At 1,000 practices, you receive your full investment back every single month.
| Your Investment | 100 Tenants | 500 Tenants | 1,000 Tenants |
|---|---|---|---|
| $5,000 | $25/mo | $125/mo | $500/mo |
| $20,000 | $100/mo | $500/mo | $2,000/mo |
| $50,000 | $250/mo | $1,250/mo | $5,000/mo |
| $100,000 | $500/mo | $2,500/mo | $10,000/mo |
Projections only. Returns are not guaranteed. Based on $1/month per $1,000 invested per active tenant. IB365 current target: 1,000 practices by end of 2026.
Reserve Your PositionOwn a piece of the platform.
For serious investors. A standard YC post-money SAFE at a $9M valuation cap. Minimum $100,000. No exotic terms. The same structure that funded Vocca, Assort Health, and Hello Patient — priced below all of them.
Why $9M is a gift
Every direct comparable raised at a higher valuation with less product. The $9M cap reflects the stage, not the product surface.
| Company | Round | Raise | Implied Post-Money | What They Had |
|---|---|---|---|---|
| Vocca | Seed — Sep 2025 | $5.5M | ~$22M | 2,000 practitioners, 4M+ calls |
| Assort Health | Seed — Mar 2024 | $3.5M | ~$15M | Voice AI MVP, early pilots |
| Hello Patient | Seed — Oct 2024 | $6.3M | ~$25M | Pilot customers only |
| IB365 | Pre-Seed SAFE — 2026 | Target $1M | $9M cap | Production system · real case study · voice + portal + CRM |
Sources: Tech.eu, FierceHealthcare, MedCity News, Crunchbase. Implied post-money based on industry-standard 20–25% dilution at seed.
“IB365 has a broader product surface than any of these companies had at their seed round — voice AI, patient portal, and practice CRM fully integrated — and is priced below all of them at $9M. This is a pre-seed price for a seed-stage product.”
“Independent practices are not a market to disrupt. They are the backbone of American medicine. We are not replacing the practitioner. We are giving them back what was taken — their time, their autonomy, their practice.”
The technology exists. The market is clear. The patients are waiting. The only thing left is scale.
The window is open. It will not stay open.
Each one is a potential IB365 customer. Each one is understaffed, overworked, and losing patients to administrative friction.
The independent practice is endangered. The ones that survive will be the ones that automate their front office. IB365 is that automation.
The market is moving. Healthcare AI captured 62% of all digital health VC funding in H1 2025. The window for pre-seed pricing is closing.
Sources: AMA Independent Practice Survey 2025, Bessemer State of Health AI 2026, Crunchbase AI Healthcare Funding 2025
$60,000 already committed.
Two early investors have already signed revenue sharing agreements. They saw the production system, reviewed the case study, and committed. $160,000 remains. First-come.
Ready to invest?
Reach out directly. No forms. No gatekeepers. Ryan responds to every inquiry personally.
Email: ryan@ib365.ai
This page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Investment in early-stage companies involves significant risk, including the potential loss of your entire investment. Past performance and current metrics are not indicative of future results. Revenue sharing projections are illustrative only. Prospective investors should consult their legal and financial advisors before making any investment decision. Securities offerings are conducted in compliance with applicable federal and state securities laws.